Genska terapija

January 24, 2026, 7:24 AM EST. Predictions for 2026 hinge on how far valuations outpace revenue in the quantum computing space. The piece argues a reckoning could arrive despite a late-2020s optimism. It notes the pure-play stocks are expensive relative to sales: D-Wave has TTM revenue around $24 million but a market cap near $10 billion; Rigetti about $12.7 million in TTM revenue with an $8.5 billion cap; QUBT (Quantum Computing) about $0.55 million in TTM revenue vs. a $3 billion cap; IonQ roughly $80 million in TTM revenue with an $18 billion cap. Skeptics, including MIT researchers and Morningstar analysts, say large-scale commercialization is years away-five to ten years for early use, possibly twenty for general-use. Prominent critics such as Gil Kalai and Mikhail Dyakonov question the feasibility of quantum error correction. The piece emphasizes the risk of overvaluation unless near-term commercialization materializes.